CHID1

Across TCGA pan-cancer cohorts, CHID1 Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated CHID1 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CHID1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CHID1 expression acts as an unfavorable survival marker.

STAD, LUSC, and DLBC are the cancer types where CHID1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.003	0.688	<.001	36	view →
LUSC	OS	Median	II,III,IV	0.275	0.744	.007	18	view →
DLBC	OS	Median	All	0.054	0.842	<.001	12	view →
SKCM	OS	Median	All	0.627	0.870	<.001	12	view →
GBM	DFS	Median	All	0.066	0.257	.019	6	view →
PRAD	DFS	Median	All	0.144	0.888	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	OS	Median	II,III,IV	0.245	0.749	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

CHID1–STAD (OS)

Open the STAD breakdown →